$850,000 to treat blindness – Will drugmakers make it?

Spark Therapeutics Inc has taken the initiative to address the rare form of blindness (due to genetic reason) that occurs in March. It is a one-time treatment but costs about $425,000 per eye. The CEO of Spark has More...